The Ewing's sarcoma gene product functions as a transcriptional activator

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2690-2695

  Rossow, Kari L ^a   Janknecht, Ralf ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GENE PRODUCT; HYBRID PROTEIN; NUCLEAR PROTEIN; PROTEIN P300;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL; CELL FUNCTION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EWING SARCOMA; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE C FOS; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MINK; NUCLEAR PROTEINS; PEPTIDE MAPPING; PROTEIN STRUCTURE, TERTIARY; RABBITS; RIBONUCLEOPROTEINS; RNA-BINDING PROTEIN EWS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 0035866778     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Chromosomal abnormalities and tumor development: From genes to therapeutic mechanisms
2. Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family
3. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
4. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation
5. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1
6. EWS/Fli-1 chimeric protein is a transcriptional activator
7. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts
8. EWS/FLI-1 amagonists induce growth inhibition of Ewing tumor cells in vitro
9. EWS-Fli 1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectudermal tumor cells
10. Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides
11. Combinaturial generation of variable fusion proteins in the Ewing family of tumours
12. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1
13. Fusion of an ETS-family gene, E1AF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy
14. A novel chimera gene between EWS and E1A-F, encoding the adenovims E1A enhancer-binding protein, in extraosseous Ewing's sarcoma
15. A new member of the ETS family fused to EWS in Ewing tumors
16. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
17. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene
18. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator
19. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor
20. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor
21. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
22. Fusion of the EWS and CHOP genes in myxoid liposarcoma
23. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma
24. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator
25. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains
26. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
27. The transcriptional repressor ZFM 1 interacts with and modulates the ability of EWS to activate transcription
28. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes
29. Transcription. A growing coactivator network
30. Conjunction dysfunction: CBP/p300 in human disease
31. Eukaryotic expression vectors for the analysis of mutant proteins
32. Activation of Smad 1-mediated transcription by p300/CBP
33. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts
34. Activation of ternary complex factor Elk-1 by MAP kinases
35. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP
36. TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300
37. Transcriptional activity and constitutive nuclear localization of the ETS protein Elf-1
38. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene
39. Signal integration at the c-fos promoter
40. The Xvent-2 homeobox gene is part of the BMP-4 signalling pathway controlling dorsoventral patterning of Xenopus mesoderm
41. Requirement for neuregulin receptor erbB2 in neural and cardiac development
42. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
43. Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro
44. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP
45. CBP-induced stimulation of c-Fos activity is abrogated by E1A
46. Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS
47. The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain
48. Transcriptional activation by the EWS oncogene can be cis-repressed by the EWS RNA-binding-domain
49. Signaling inputs converge on nuclear effectors in TGF-β signaling
50. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS
51. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
52. Abnormal skeletal patterning in embryos lacking a single Cbp allele: A partial similarity with Rubinstein-Taybi syndrome
53. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
54. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
55. Mutations truncating the EP300 acetylase in human cancers
56. CBP/p300 in cell growth, transformation, and development
57. Bone and haematopoietic defects in mice lacking c-fos
58. Modulation of EWS/WT1 activity by the v-Src protein tyrosine kinase
59. Modification of EWS/WT1 functional properties by phosphorylation